ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?

by Yu. S. Shatova, V. V. Tokmakov, L. Yu. Vladimirova, L. N. Vaschenko
Published 2017-12-01

Expression level of androgen receptors in tumor tissue and its prognostic significance in primary operable luminal breast cancer without overexpression of Her2/neu in postmenopausa...

by O I Kit, Yu S Shatova, V V Tokmakov, I A Novikova, E P Ul’yanova, E Yu Zlatnik
Published 2019-12-01

The local hormonal environment of tumor and perifocal zone in patients with breast cancer: data and prospects of their application

by Yu. S. Shatova, E. M. Frantsiyants, I. A. Novikova, L. N. Vashchenko, V. A. Bandovkina, M. I. Vereskunova, A. N. Khugaeva, V. V. Tokmakov
Published 2016-11-01

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor

by V. V. Tokmakov, E. P. Ulianova, Yu. S. Shatova, A. B. Sagakyants, N. M. Mashchenko, I. A. Novikova, E. M. Nepomnyashchaya, O. G. Shulgina
Published 2020-12-01